Vermillion, Inc.
(NASDAQ : VRML)

( )
VRML PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
0.00%183.551.1%$846.87m
GILDGilead Sciences, Inc.
0.00%80.700.9%$816.69m
CELGCelgene Corporation
0.00%95.261.2%$791.42m
JUNOJuno Therapeutics, Inc.
0.00%85.1013.5%$584.15m
BIIBBiogen Inc.
0.00%291.871.2%$500.99m
REGNRegeneron Pharmaceuticals, Inc.
0.00%332.152.7%$399.78m
VRTXVertex Pharmaceuticals Incorporated
0.00%160.721.9%$358.41m
ALXNAlexion Pharmaceuticals, Inc.
0.00%120.472.0%$256.63m
NKTRNektar Therapeutics
0.00%83.436.0%$246.17m
ILMNIllumina, Inc.
0.00%229.203.5%$234.08m
BLUEBluebird Bio, Inc.
0.00%213.3516.1%$201.76m
AAgilent Technologies, Inc.
0.00%71.941.5%$173.78m
INCYIncyte Corporation
0.00%86.032.5%$158.32m
EXASExact Sciences Corporation
0.00%48.8626.0%$132.16m
BMRNBioMarin Pharmaceutical Inc.
0.00%84.984.4%$122.34m

Company Profile

Vermillion, Inc. engages in the provision of bio-analytic and diagnostic services. Its product, OVA1, is a serum test for identifying women of having malignant ovarian tumor. The company was founded on December 9, 1993 and is headquartered in Austin, TX.